Schmoll, H.J., Cartwright, T., Tabemero, J., Nowacki, M.P., Figer, A., Maroun, J., et al. (2007) Phase III Trail of Capecitabine plus Oxaliplatin as Adiuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients. Journal of Clinical Oncology, 25, 102-109.